vs
COMPX INTERNATIONAL INC(CIX)与RECURSION PHARMACEUTICALS, INC.(RXRX)财务数据对比。点击上方公司名可切换其他公司
COMPX INTERNATIONAL INC的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.1倍($37.7M vs $35.5M),COMPX INTERNATIONAL INC净利率更高(12.4% vs -304.2%,领先316.6%),RECURSION PHARMACEUTICALS, INC.同比增速更快(681.7% vs -1.9%),COMPX INTERNATIONAL INC自由现金流更多($11.4M vs $-47.3M),过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高(60.5% vs -0.4%)
COMPX国际是一家多元化安全与控制产品制造商,主营高性能锁具系统、电子门禁解决方案、人体工学工作站部件及船用五金,核心市场覆盖北美、欧洲,服务商业、住宅、工业、医疗、休闲船舶等领域客户。
Recursion Pharmaceuticals是一家临床阶段生物技术企业,依托人工智能技术和高通量生物实验体系,开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法,核心市场覆盖北美,与全球多家生物制药企业合作推进在研管线落地。
CIX vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $37.7M | $35.5M |
| 净利润 | $4.7M | $-108.1M |
| 毛利率 | 32.1% | 59.8% |
| 营业利润率 | 15.0% | -304.8% |
| 净利率 | 12.4% | -304.2% |
| 营收同比 | -1.9% | 681.7% |
| 净利润同比 | 3.6% | 39.6% |
| 每股收益(稀释后) | $0.38 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
| Q4 25 | $37.7M | $35.5M | ||
| Q3 25 | $40.0M | $5.2M | ||
| Q2 25 | $40.4M | $19.2M | ||
| Q1 25 | $40.3M | $14.7M | ||
| Q4 24 | $38.4M | $4.5M | ||
| Q3 24 | $33.7M | $26.1M | ||
| Q2 24 | $35.9M | $14.4M | ||
| Q1 24 | $38.0M | $13.8M |
| Q4 25 | $4.7M | $-108.1M | ||
| Q3 25 | $4.2M | $-162.3M | ||
| Q2 25 | $5.5M | $-171.9M | ||
| Q1 25 | $5.1M | $-202.5M | ||
| Q4 24 | $4.5M | $-178.9M | ||
| Q3 24 | $3.5M | $-95.8M | ||
| Q2 24 | $4.8M | $-97.5M | ||
| Q1 24 | $3.8M | $-91.4M |
| Q4 25 | 32.1% | 59.8% | ||
| Q3 25 | 27.6% | -183.8% | ||
| Q2 25 | 31.9% | -4.9% | ||
| Q1 25 | 30.2% | -48.0% | ||
| Q4 24 | 28.8% | -181.4% | ||
| Q3 24 | 28.1% | 53.7% | ||
| Q2 24 | 31.1% | 36.2% | ||
| Q1 24 | 25.5% | 19.1% |
| Q4 25 | 15.0% | -304.8% | ||
| Q3 25 | 11.9% | -3327.6% | ||
| Q2 25 | 15.7% | -916.8% | ||
| Q1 25 | 14.6% | -1297.9% | ||
| Q4 24 | 12.7% | -4042.4% | ||
| Q3 24 | 9.9% | -377.1% | ||
| Q2 24 | 14.2% | -697.4% | ||
| Q1 24 | 9.8% | -698.4% |
| Q4 25 | 12.4% | -304.2% | ||
| Q3 25 | 10.6% | -3135.3% | ||
| Q2 25 | 13.5% | -894.2% | ||
| Q1 25 | 12.7% | -1373.3% | ||
| Q4 24 | 11.7% | -3935.5% | ||
| Q3 24 | 10.3% | -367.5% | ||
| Q2 24 | 13.5% | -676.6% | ||
| Q1 24 | 9.9% | -662.4% |
| Q4 25 | $0.38 | $-0.17 | ||
| Q3 25 | $0.34 | $-0.36 | ||
| Q2 25 | $0.44 | $-0.41 | ||
| Q1 25 | $0.42 | $-0.50 | ||
| Q4 24 | $0.37 | $-0.56 | ||
| Q3 24 | $0.28 | $-0.34 | ||
| Q2 24 | $0.39 | $-0.40 | ||
| Q1 24 | $0.31 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $54.1M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $138.6M | $1.1B |
| 总资产 | $156.2M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势,按日历期对齐
| Q4 25 | $54.1M | $743.3M | ||
| Q3 25 | $46.3M | $659.8M | ||
| Q2 25 | $56.2M | $525.1M | ||
| Q1 25 | $56.1M | $500.5M | ||
| Q4 24 | $60.8M | $594.4M | ||
| Q3 24 | $58.8M | $427.6M | ||
| Q2 24 | $82.1M | $474.3M | ||
| Q1 24 | $75.6M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $138.6M | $1.1B | ||
| Q3 25 | $137.7M | $1.0B | ||
| Q2 25 | $149.5M | $919.1M | ||
| Q1 25 | $147.6M | $933.9M | ||
| Q4 24 | $146.1M | $1.0B | ||
| Q3 24 | $145.3M | $524.6M | ||
| Q2 24 | $170.2M | $584.4M | ||
| Q1 24 | $168.9M | $401.2M |
| Q4 25 | $156.2M | $1.5B | ||
| Q3 25 | $153.7M | $1.4B | ||
| Q2 25 | $164.8M | $1.3B | ||
| Q1 25 | $162.2M | $1.3B | ||
| Q4 24 | $163.0M | $1.4B | ||
| Q3 24 | $160.1M | $726.5M | ||
| Q2 24 | $185.1M | $775.9M | ||
| Q1 24 | $181.7M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $12.0M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $11.4M | $-47.3M |
| 自由现金流率自由现金流/营收 | 30.3% | -133.1% |
| 资本支出强度资本支出/营收 | 1.6% | 3.5% |
| 现金转化率经营现金流/净利润 | 2.57× | — |
| 过去12个月自由现金流最近4个季度 | $19.1M | $-378.3M |
8季度趋势,按日历期对齐
| Q4 25 | $12.0M | $-46.1M | ||
| Q3 25 | $6.3M | $-117.4M | ||
| Q2 25 | $4.7M | $-76.4M | ||
| Q1 25 | $-137.0K | $-132.0M | ||
| Q4 24 | $7.3M | $-115.4M | ||
| Q3 24 | $4.1M | $-59.2M | ||
| Q2 24 | $9.8M | $-82.2M | ||
| Q1 24 | $1.7M | $-102.3M |
| Q4 25 | $11.4M | $-47.3M | ||
| Q3 25 | $5.3M | $-117.6M | ||
| Q2 25 | $3.4M | $-79.6M | ||
| Q1 25 | $-959.0K | $-133.8M | ||
| Q4 24 | $7.1M | $-116.7M | ||
| Q3 24 | $3.6M | $-63.8M | ||
| Q2 24 | $9.4M | $-83.4M | ||
| Q1 24 | $1.4M | $-109.0M |
| Q4 25 | 30.3% | -133.1% | ||
| Q3 25 | 13.2% | -2272.5% | ||
| Q2 25 | 8.4% | -413.9% | ||
| Q1 25 | -2.4% | -907.4% | ||
| Q4 24 | 18.5% | -2567.7% | ||
| Q3 24 | 10.8% | -244.6% | ||
| Q2 24 | 26.2% | -578.5% | ||
| Q1 24 | 3.6% | -789.9% |
| Q4 25 | 1.6% | 3.5% | ||
| Q3 25 | 2.5% | 4.7% | ||
| Q2 25 | 3.3% | 16.4% | ||
| Q1 25 | 2.0% | 12.4% | ||
| Q4 24 | 0.6% | 28.6% | ||
| Q3 24 | 1.4% | 17.5% | ||
| Q2 24 | 1.2% | 8.2% | ||
| Q1 24 | 0.8% | 48.2% |
| Q4 25 | 2.57× | — | ||
| Q3 25 | 1.48× | — | ||
| Q2 25 | 0.87× | — | ||
| Q1 25 | -0.03× | — | ||
| Q4 24 | 1.62× | — | ||
| Q3 24 | 1.18× | — | ||
| Q2 24 | 2.03× | — | ||
| Q1 24 | 0.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CIX
| Security Products | $29.5M | 78% |
| Marine Components | $8.2M | 22% |
RXRX
暂无分部数据